Results 101 to 110 of about 25,204 (165)

ctDNA and immune biomarker testing for molecular residual disease surveillance and immune stratification in cancer. [PDF]

Front Med (Lausanne)
Cui N, Hao H, Hu X, Li Y.
europepmc   +1 more source

Longitudinal ctDNA tracking in early and recurrent breast cancer using an ultrasensitive structural variant-based assay: an extended analysis from the TRACER study. [PDF]

ESMO Open
Elliott MJ, Roh J, Bird T, Li M, Nadler MB, Amir E, Kumar V, Yu C, Alcaide M, Birkeälv S, Hafstad V, Gray E, de Bruin EC, Levin W, Siu LL, Bedard PL, Berman HK, Howarth K, Cescon DW.   +18 more
europepmc   +1 more source

Circulating Tumor DNA in Bladder Cancer: Current Clinical Evidence and Emerging Multi-Omics Perspectives-A Narrative Review. [PDF]

Cancers (Basel)
Polito MG, Sisca L, Caruso D, Cosimati A, Ramirez Reinaga CA, Leka E, Santini D, Spinelli GP.   +7 more
europepmc   +1 more source

Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab. [PDF]

JCO Precis Oncol
Balic M, Tang G, Rastogi P, Young G, Wallace M, Acosta J, Schneeweiss A, Hilton CJ, Freeman TJ, Li J, Denkert C, Reinisch M, Palomares MR, Arrick BA, Petitt M, Maley SK, Hassan S, Murali S, Boileau JF, Boudreau D, Polewski PJ, Mashru S, Hargis JB, Mortimer J, Thirlwell M, Sikov W, Tan AR, Garces J, Costa G, LoBello J, Mouta J, Darbonne WC, Baehner FL, Mamounas EP, Wolmark N, Loibl S, Geyer CE.   +36 more
europepmc   +1 more source

Circulating tumor DNA in neoadjuvant therapy for solid tumors. [PDF]

Front Oncol
Huang X, Deng Y, Shen Y.
europepmc   +1 more source

Circulating Tumor DNA in Breast Cancer: A Liquid Biopsy Revolution for Non-Invasive Genomic Profiling and Clinical Decision-Making. [PDF]

Breast Cancer (Auckl)
Obeagu EI, Okafor CJ.
europepmc   +1 more source

Liquid Biopsies for Cancer: A Translational Science Review. [PDF]

JAMA
Mezzanotte-Sharpe J, Piemonte K, Park BH.   +2 more
europepmc   +1 more source

Circulating Tumor DNA-Based Molecular Residual Disease in Early-Stage Non-Small-Cell Lung Cancer: Biology, Assays, and the Path Toward MRD-Guided Care. [PDF]

Cancers (Basel)
Yadav R, Ito M, Ujiie H, Ohara S, Tsutani Y, Sunny G.   +5 more
europepmc   +1 more source